Musculoskeletal and rheumatological disorders in HIV infection: Experience in a tertiary referral center

Evaluation of the mandibular condylar bone microarchitecture in people living with HIV

OBJECTIVES

People living with HIV (PLWH) have been shown to have lower bone density at the spine, hip, and radius. However, whether a similar bone phenotype is seen in craniofacial bones is not known. The goal of this study was to evaluate the bone microarchitecture of the mandibular condyle in PLWH.

METHODS

We recruited 212 participants, which included 88 HIV-negative participants and 124 PLWH on combination antiretroviral therapy with virological suppression from a single academic center. Each participant filled out a validated temporomandibular disorder (TMD) pain screening questionnaire and had cone beam computed tomography (CBCT) of their mandibular condyles. Qualitative radiographic evidence of temporomandibular joint disorders-osteoarthritis (TMJD-OA) assessment and quantitative microarchitecture analysis of their mandibular condylar bones were conducted.

RESULTS

There was no statistically significant difference in either self-reported TMD or in radiographic evidence of TMJD-OA in PLWH compared with HIV-negative controls. Linear regression analysis revealed that positive HIV status remained significantly associated with increased trabecular thickness, decreased cortical porosity, and increased cortical bone volume fraction after adjusting for race, diabetes, sex, and age.

CONCLUSION

PLWH have increased mandibular condylar trabecular bone thickness and cortical bone volume fraction compared with HIV-negative controls.

A Review of the Use of Biological Agents in Human Immunodeficiency Virus Positive Patients With Rheumatological Diseases

After approval, initial biologics etanercept, infliximab, and adalimumab became useful in the therapeutic armamentarium to treat rheumatoid arthritis (RA) patients who had an inadequate response to disease-modifying anti-rheumatic drugs (DMARDs). However, all phase-III clinical trials submitted to the FDA, by design, excluded patients who were human immunodeficiency virus (HIV) positive. They are another subset of patients with low immunity due to their HIV-positive status. Very little information is available about the use of biologics in this new group of patients if they fail to respond to DMARDS. The available literature is limited to case reports about HIV-positive RA patients with reported side effects. These side effects range from no opportunistic infections (OIs) in some to acute respiratory distress syndrome (ARDS) and disseminated intravascular coagulopathy (DIC) reported in others. Some HIV cases may initially present with rheumatological manifestations. With growing epidemiologic evidence of frequent joint manifestations in HIV-positive patients, HIV testing should be done more frequently in patients with RA, even those who deny risk factors for HIV. This review may help develop future guidelines on how to manage HIV-positive RA patients.

Functional analysis of lower limbs in individuals infected with the human immunodeficiency virus

OBJECTIVES

The objective of this research was to analyze the functional changes of lower limbs by means of surface electromyography in patients with acquired immunodeficiency syndrome.

METHODS

A total of 60 men and women (age mean of 36.77 ± 9.33 years) were divided into two groups: 30 individuals with human immunodeficiency virus group (HIVG) Subtype 1 and 30 healthy individuals control group. Muscle activity was evaluated using surface electromyography (sEMG). sEMG measurements were made while the subjects assumed the static positions: Rest in orthostatism (RS), squat "normalization factor," right and left single leg support (RSLS, LSLS) and during functional activities: Right and left single leg step rise (RSLSR, LSLSR), right and left single leg step down (RSLSD, LSLSD), rising and seating on a chair (RC, SC).

RESULTS

To sEMG results revealed statistically significant values in the conditions of RSLS to left semitendinosus muscle, for LSLS to right and left semitendinosus, right rectus femoris and right gluteus medius muscles, for LSLSR to right rectus femoris and right tensor fasciae latae muscles, for RSLSD to right and left semitendinosus and right rectus femoris muscles, for RC to right rectus femoris and left gluteus medius muscles and for SC to right semitendinosus, right rectus femoris and right and left gluteus medius muscles.

CONCLUSION

It can be concluded that individuals with acquired immunodeficiency syndrome presented changes in lower limb muscle activity.